Primær forebyggelse af kardiovaskulære hændelser med acetylsalicylsyre hos patienter med type 2-diabetes mellitus

Victoria Rosberg, Erik Lerkevang Grove, Hans Erik Bøtker, Steen Dalby Kristensen, Manan Pareek

Abstract

This review assesses the latest evidence and guidelines related to the use of aspirin for primary prevention among patients with Type 2 diabetes (T2D) without overt cardiovascular disease. The global burden of T2D is steadily increasing and most deaths among patients with T2D are attributed to cardiovascular events. Furthermore, several haemostatic abnormalities have been shown in this group of patients, including increased platelet turnover and aggregation.

Bidragets oversatte titelAcetylsalicylic acid for primary prevention of cardiovascular events in patients with Type 2 diabetes mellitus
OriginalsprogDansk
ArtikelnummerV03190205
TidsskriftUgeskrift for Laeger
Vol/bind181
Udgave nummer41
ISSN0041-5782
StatusUdgivet - 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Primær forebyggelse af kardiovaskulære hændelser med acetylsalicylsyre hos patienter med type 2-diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Citationsformater